Leland Gershell analyst OPPENHEIMER

Currently out of the existing stock ratings of Leland Gershell, 128 are a BUY (92.75%), 5 are a SELL (3.62%), 5 are a HOLD (3.62%).

Leland Gershell

Work Performance Price Targets & Ratings Chart

Analyst Leland Gershell works at OPPENHEIMER with a stock forecast success ratio of 30.15% fulfilled within 118.32 days on average.

Leland Gershell’s has documented 302 price targets and ratings displayed on 37 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on CRNX, Crinetics Pharmaceuticals at 29-Feb-2024.

Wall Street Analyst Leland Gershell

Analyst best performing recommendations are on BXRX (BAUDAX BIO ).
The best stock recommendation documented was for BXRX (BAUDAX BIO ) at 1/21/2020. The price target of $11200 was fulfilled within 1 day with a profit of $1344 (13.64%) receiving and performance score of 136.36.

Average potential price target upside

ACST Acasti Pharma ADMA ADMA Biologics AGRX Agile Thrpe ALNY Alnylam Pharmaceuticals AMRN Amarin PLC ASND Ascendis Pharma AS BMRN Biomarin Pharmaceutical BXRX Baudax Bio  CASI CASI Pharmaceuticals CERC Cerecor CPRX Catalyst Pharmaceuticals EVFM Evofem Biosciences MGEN Viridian Therapeutics MIST Milestone Pharmaceuticals REPH Recro Pharma TARA Protara Therapeutics URGN UroGen Pharma Ltd VERU Veru BBI Brickell Biotech PLXP PLx Pharma CRXT Clarus Therapeutics Holdings HZNP Horizon Pharma PLC LUMO Lumos Pharma AVTX Avalo Therapeutics CLNN Clene . TRVI Trevi Therapeutics XLRN Acceleron Pharma CRBP Corbus Pharmaceuticals EPZM Epizyme OTLK OUTLOOK THERAPEUTICS INC SLNO Soleno Therapeutics XFOR X4 Pharmaceuticals NCNA NuCana PLC TEVA Teva Pharma Industries Ltd ADR VRDN Viridian Therapeutics CRNX Crinetics Pharmaceuticals PDSB PDS Biotechnology Corp

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$-0.28 (-10.07%)

1 years 15 days ago

1/1 (100%)

$1.86 (290.63%)




1 years 8 months 8 days ago

0/1 (0%)

$22.32 (290.63%)


3 years 5 months 30 days ago

0/1 (0%)

$59.52 (163.16%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Leland Gershell is most bullish on?

Potential upside of $17.29 has been obtained for VRDN (VIRIDIAN THERAPEUTICS)

Which stock is Leland Gershell is most reserved on?

Potential downside of -$1.32 has been obtained for SLNO (SOLENO THERAPEUTICS)

What Year was the first public recommendation made by Leland Gershell?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?